Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erkang Fan

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
Journal of Molecular Biology|March 23, 2011
The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimerEric T Larson, Jessica E Kim, Lisa J Castaneda, et al.
International Journal for Parasitology|September 14, 2017
In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoitesAlejandro Jiménez-Meléndez, Kayode K Ojo, Alexandra M Wallace, et al.
ACS Infectious Diseases|September 15, 2016
5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase InhibitorsZhongsheng Zhang, Cho Yeow Koh, Ranae M Ranade, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1Zhongsheng Zhang, Kayode K Ojo, Steven M Johnson, et al.
Journal of Biomolecular Screening|August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screeningLaura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Journal of Molecular Biology|July 8, 2008
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivityEric T Larson, Wei Deng, Brian E Krumm, et al.
The Journal of Infectious Diseases|July 24, 2013
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosisAlejandro Castellanos-Gonzalez, A Clinton White, Kayode K Ojo, et al.
Plos Neglected Tropical Diseases|April 19, 2014
Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sicknessCho Yeow Koh, Jessica E Kim, Allan B Wetzel, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
Journal of Molecular Biology|March 23, 2011
The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimerEric T Larson, Jessica E Kim, Lisa J Castaneda, et al.
International Journal for Parasitology|September 14, 2017
In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoitesAlejandro Jiménez-Meléndez, Kayode K Ojo, Alexandra M Wallace, et al.
ACS Infectious Diseases|September 15, 2016
5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase InhibitorsZhongsheng Zhang, Cho Yeow Koh, Ranae M Ranade, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1Zhongsheng Zhang, Kayode K Ojo, Steven M Johnson, et al.
Journal of Biomolecular Screening|August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screeningLaura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Journal of Molecular Biology|July 8, 2008
Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivityEric T Larson, Wei Deng, Brian E Krumm, et al.
The Journal of Infectious Diseases|July 24, 2013
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosisAlejandro Castellanos-Gonzalez, A Clinton White, Kayode K Ojo, et al.
Plos Neglected Tropical Diseases|April 19, 2014
Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sicknessCho Yeow Koh, Jessica E Kim, Allan B Wetzel, et al.
Pageof 11